Ace the 2026 Orthopaedic Nurses Certification: Master Metabolic, Inflammatory & Tumor Challenges!

Bisphosphonates are a class of drugs specifically designed to inhibit bone resorption, making them effective in treating osteoporosis. They work by binding to the bone and reducing the activity of osteoclasts, the cells responsible for bone breakdown. This action helps to improve bone density and reduce the risk of fractures, which is particularly important in individuals with osteoporosis as they are at increased risk for bone injuries.

Calcium supplements are often used as an adjunct treatment to provide the necessary building blocks for bone formation but do not directly treat the underlying problem of excessive bone resorption. Antibiotics are prescribed for infections and have no impact on bone density or osteoporosis. Nonsteroidal anti-inflammatory drugs (NSAIDs) primarily manage pain and inflammation, but they do not play a direct role in strengthening bones or improving bone density in osteoporosis patients. Therefore, bisphosphonates stand out as the primary pharmacological option for directly addressing osteoporosis.